Loading candles…
Vijaya Diagnostic Centre Limited, incorporated in 1981, operates in the healthcare and diagnostic services industry primarily across Southern India, with a focus on Telangana and Andhra Pradesh. The company offers a range of diagnostic and medical services including nuclear medicine, radiology, laboratory testing, pathology and radiology tests, health check-ups, and advanced imaging such as PET-CT and 3T MRI. It delivers these services through a network that follows a hub-and-spoke model. As of December 2025, the company’s network reportedly includes either 81 diagnostic centers and 11 reference laboratories per one source, or 162 diagnostic centres across 27 cities and towns according to another, with an emphasis on serving a substantial business-to-consumer customer base. The company provides over 2,000 pathology and 700 radiology tests, expanding its reach across multiple cities in Southern India. There is no publicly available information on its founders, key management, subsidiaries, or listings.
This page is a live market overview for VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) on the NSE. As a listed security, VIJAYA DIAGNOSTIC CEN LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VIJAYA before placing trades on tick2trade.
As of the latest feed, VIJAYA last traded at ₹1,351.1 on NSE, down ₹18.7 (1.37%) from the previous close of ₹1,369.8. Today's session range is ₹1,340 – ₹1,433, against a 52-week band of ₹848 – ₹1,440. Traded volume today stands at 5.76L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for VIJAYA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VIJAYA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VIJAYA DIAGNOSTIC CEN LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VIJAYA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VIJAYA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 6 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 7 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 13 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 4 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 28 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | 12 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.